Friday, June 28, 2019 1:55:24 PM
They are digging a deeper hole if they are not being forthright.
NWBO has many regulatory eyes watching them -- including, NWBO tells us themselves -- the SEC. So I'd hope they are not deliberately pulling a fast one. Can you imagine how messy that would be? Nah, I think Dr. Bosch does not believe they are going to get stymied by regulators (FDA, PEI, etc), nor do I think they would set themselves up to be stymied, particularly not with all the independent experts working on this.
They had more money to do this SAP right from the property flip profit at the turn of the year. Paid these big time independents up front to prepare the SAP, and now they are apparently at the cusp of SAP submission and hopefully soon thereafter, SAP "buy-in," imho.
NWBO has many regulatory eyes watching them -- including, NWBO tells us themselves -- the SEC. So I'd hope they are not deliberately pulling a fast one. Can you imagine how messy that would be? Nah, I think Dr. Bosch does not believe they are going to get stymied by regulators (FDA, PEI, etc), nor do I think they would set themselves up to be stymied, particularly not with all the independent experts working on this.
They had more money to do this SAP right from the property flip profit at the turn of the year. Paid these big time independents up front to prepare the SAP, and now they are apparently at the cusp of SAP submission and hopefully soon thereafter, SAP "buy-in," imho.
Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
